Eli Lilly is sharpening its competitive edge in the crowded oral SERD arena as the FDA has approved a combination of its ...

Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports.

Roche’s T-cell engager portfolio has notched another milestone, as a phase 3 trial of the company’s Lunsumio met its primary ...

Eli Lilly is marking World Alzheimer’s Day with a partnership to distribute 13,500 boxes of brain-healthy fresh produce and ...

Following the news that longtime helmsman Paul Chaplin would be hanging up his hat at Bavarian Nordic earlier this year, the ...

In their lawsuit, BMS and Ono accuse Amgen of aiming to market its biosimilar ahead of the expiration of key U.S. patents ...

Comedian Damon Wayans, a patient advocate and spokesperson for the humor-forward Genentech campaign “All Eyes of DME,” said that element is at the heart of his work with the Roche subsidiary to raise ...

Consumer drug behemoth Reckitt is dropping $600 million on a multi-year revamp of its U.S. operations. The health and hygiene ...

Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of ...

Some 1,000 patients with a specific form of advanced breast cancer in England can, at last, receive AstraZeneca and Daiichi ...

Fayuvi, previously known as UX111, uses an adeno-associated viral vector to deliver a working copy of the SGSH gene into the patient’s cells. It marks the first FDA-approved therapy designed to ...

Bayer just scored another label expansion for its blockbuster-in-waiting, Kerendia. | The heart and kidney med earned the first FDA nod in three decades for adults with chronic kidney disease ...